Big Medicare change slashes weight-loss drug costs for eligible seniors

Millions of Medicare beneficiaries struggling with obesity could soon spot the outgo of weight-loss drugs plummet, arsenic a caller national aviator programme launching July 1 expands entree to GLP-1 medications similar Wegovy and Zepbound for eligible seniors.

Through a caller proceedings called Medicare GLP-1 Bridge, the national authorities is present offering a enactment of the brand-name medications to definite Medicare and Medicare Advantage beneficiaries for $50 a month, The Associated Press reported.

The covered medications see drugmaker Eli Lilly’s Foundayo tablets and Zepbound KwikPens and Novo Nordisk’s Wegovy injections and tablets, each of which person been FDA-approved for value loss, according to the report.

OZEMPIC USERS MAY BE MAKING A MAJOR WEIGHT-LOSS MISTAKE, NEW STUDY SUGGESTS

The impermanent programme is acceptable to tally until the extremity of 2027.

This is the archetypal clip GLP-1s (glucagon-like peptide-1 receptor agonists) volition beryllium covered by security erstwhile utilized solely for value loss.

A caller national aviator programme launching July 1 expands entree to GLP-1 medications similar Wegovy and Zepbound for eligible seniors. (iStock)

Prior to this caller Medicare pilot, seniors who wanted to entree GLP-1s for obesity unsocial paid astir $1,350-$1,650 per period for Novo Nordisk’s Wegovy (semaglutide) and astir $1,086 monthly for Lilly’s Zepbound (tirzepatide). However, some manufacturers offered immoderate cash-pay options that importantly reduced those prices for eligible patients.

GLP-1 WEIGHT LOSS DRUGS ARE RESHAPING THE BRIDAL INDUSTRY AS SHOPS RUSH ORDERS AND REQUIRE NEW WAIVERS

There are immoderate parameters surrounding the sum — older adults indispensable person had a assemblage wide scale (BMI) of 35 oregon higher erstwhile they started GLP-1 therapy, oregon a BMI of 27 oregon higher alongside different wellness condition, specified arsenic a past bosom onslaught oregon changeable oregon prediabetes.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Those who already person security sum for different diseases, specified arsenic diabetes and slumber apnea, are not eligible for the program.

Through a caller proceedings called Medicare GLP-1 Bridge, the national authorities is present offering a enactment of the brand-name medications to definite Medicare and Medicare Advantage beneficiaries for $50 a month. (iStock)

There are much than 70 cardinal Americans presently enrolled successful Medicare, 10 cardinal of whom are overweight oregon obese, according to Juliette Cubanski, vice president and manager of the programme connected Medicare argumentation astatine the healthcare probe nonprofit KFF.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

"For galore older Americans surviving with obesity, this is simply a infinitesimal they and their families person been waiting for," Jamey Millar, Novo Nordisk’s enforcement vice president of U.S. operations, said successful a property release.

"The Medicare GLP-1 Bridge programme offers a new, affordable way to an FDA-approved attraction that was antecedently not covered."

CLICK HERE FOR MORE HEALTH STORIES

Dr. Mehmet Oz, head of the Centers for Medicare & Medicaid Services, said helium hopes the programme tin assistance his bureau cod information to perchance enactment toward longer-term coverage, portion providing contiguous alleviation to cash-strapped older Americans, AP reported.

"The sheer outgo of these medications is simply a immense obstruction to access," helium said successful a telephone with reporters. "That ends today."

Prior to this caller Medicare pilot, seniors who wanted to entree GLP-1s for obesity unsocial paid astir $1,350-$1,650 per period for Novo Nordisk’s Wegovy (semaglutide) and astir $1,086 monthly for Lilly’s Zepbound (tirzepatide).  (iStock)

Oz told reporters that CMS plans to "carefully way information and outcomes" to spot whether an hold of the Bridge programme oregon different solution is the champion mode to determination forward. He told AP a national instrumentality permanently allowing the sum is "not indispensable close now" but thing "for Congress to statement amongst themselves."

"We can’t determine what’s going to hap agelong word with Bridge until we spot immoderate of the data," helium said, adding that determination are ongoing talks with cause companies to little costs.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

One imaginable interest is that older patients thin to person much adverse effects to medicine successful wide , according to Dr. Micah Eimer, a objective adjunct prof of cardiology astatine the Northwestern University Feinberg School of Medicine.

"Specifically, successful our research, older patients connected humor unit medications were much apt to acquisition hypotensive broadside effects, specified arsenic fainting and dizziness, aft starting a GLP-1," helium said successful a statement.

The Associated Press contributed to this report.